Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2/3 1

Status

Completed 4Recruiting 2

Sponsor Class

OTHER 6

Study Type

Observational 4Interventional 2

Sponsor

Cancer Type

Gastrointestinal 12Other 6Genitourinary 1

Conditions

Obesity 373Neoplasms 134Breast Neoplasms 95Mucositis 94Overweight 91Sexual Dysfunction, Physiological 90Polycystic Ovary Syndrome 89Dyspnea 56Motor Activity 54Weight Loss 38Constipation 35Diabetes Mellitus 33Prostatic Neoplasms 32Head and Neck Neoplasms 30Colorectal Neoplasms 30Endometrial Neoplasms 26Lung Neoplasms 25Depression 25Diabetes Mellitus, Type 2 23Cardiovascular Diseases 23Multiple Endocrine Neoplasia Type 1 22Pain 20Anxiety Disorders 20Insulin Resistance 19Obesity, Morbid 18Pulmonary Disease, Chronic Obstructive 17Hypertension 17Sexual Dysfunctions, Psychological 16Metabolic Syndrome 16Colonic Neoplasms 16

Interventions

penclomedine 1Glucose Tolerance Test 1Exenatide 1Excitatory Amino Acids 1Amino Acids, Essential 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
OTHER × Fatty Liver × Other × Clear all
NCT03717935 2025-03-24

ORANGE

University of Colorado, Denver

Phase NA Completed
27 enrolled 15 charts
Other

Fatty Liver, Obesity, Polycystic Ovary Syndrome

NCT02157974 2024-06-04

APPLE

University of Colorado, Denver

Phase 2/3 Completed
92 enrolled 17 charts
Other

Fatty Liver, Obesity, Polycystic Ovary Syndrome

NCT03041129 2024-04-17

PLUM

University of Colorado, Denver

Completed
19 enrolled 10 charts
Other

Fatty Liver, Obesity, Polycystic Ovary Syndrome

NCT05475054 2023-02-15

MILSOBES

Fondazione Poliambulanza Istituto Ospedaliero

Completed
9,963 enrolled
GastrointestinalOther

Fatty Liver, Liver Neoplasms, Obesity, Overweight

NCT04442334 2023-01-06

The European NAFLD Registry

Newcastle University

Recruiting
10,000 enrolled
GastrointestinalOther

Cardiovascular Diseases, Diabetes Mellitus, Type 2, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Hypertension, Liver Cirrhosis, Obesity, Dyslipidemias, Non-alcoholic Fatty Liver Disease

NCT04371042 2020-05-01

PROMETEO

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Recruiting
5,000 enrolled
GastrointestinalOther

Diabetes Mellitus, Fatty Liver, Fibrosis, Carcinoma, Hepatocellular, Liver Neoplasms, Obesity, Metabolic Syndrome, Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡